Skip to content

Clinical trials

Post-Acute COVID-19 Syndrome trials in the United Kingdom with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Status: Unknown status Country / region: United Kingdom Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20221
20236

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status7

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
King's College London1
Oxford Brookes University1
Royal Brompton & Harefield NHS Foundation Trust1
Sheffield Hallam University1
University College, London1
University of Bath1
University of Leeds1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome7
Anxiety Disorders2
COVID-192
Dyspnea2
Acquired Immunodeficiency Syndrome1
Amyotrophic Lateral Sclerosis1
Anemia, Sickle Cell1
Arthritis1
Arthritis, Rheumatoid1
Asthma1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.